|
시장보고서
상품코드
2050855
오피오이드 약물 시장 : 약제 클래스별, 용도별, 투여 경로별, 유통 채널별, 지역별Opioid Drugs Market, By Drug Class, By Application, By Route of Administration, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
오피오이드 약물 시장은 2026년에 497억 달러로 추정되고, 2033년에 632억 3,000만 달러에 이를 것으로 예상되고 있습니다. 또한, 2026-2033년 CAGR 3.5%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 497억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 3.50% | 2033년 시장 규모 예측 : | 632억 3,000만 달러 |
오피오이드는 주로 통증 완화에 사용되는 약물의 일종입니다. 최초의 오피오이드 계열 약물 중 하나인 '모르핀'은 1803년에 개발되었습니다. 오피오이드 계열 약물은 중추신경계와 말초신경계에 존재하는 오피오이드 수용체에 작용하여 통증을 완화합니다. 오피오이드는 경구용 정제, 주사제, 액상, 패치, 또는 마취제 등의 형태로 투여됩니다. 펜타닐, 옥시코돈, 모르핀, 코데인, 옥시몰폰, 하이드로코돈 등 의사가 통증 치료를 위해 배합하는 다양한 유형의 복합 오피오이드가 있습니다.
시장 역학
오피오이드 수용체와 뉴로키닌 수용체를 표적으로 하는 하이브리드 화합물 합성에 대한 연구개발 증가는 시장 관계자들에게 유망한 성장 기회를 제공할 것으로 예측됩니다. 예를 들어, 2019년 12월, 우치의과대학 연구진은 오피오이드 유도체와 서브스턴스 P(SP) 단편 또는 뉴로키닌 수용체(NK1) 길항제 단편을 결합한 일련의 하이브리드 화합물의 합성, 구조-활성 상관관계, 약리학적 특성에 대해 보고했습니다. 이는 오피오이드에 의한 항통증 작용에서 뉴로키닌계의 역할을 규명하기 위한 것입니다.
시장의 주요 기업들은 제품 포트폴리오를 확대하기 위해 제품 승인 및 출시에 주력하고 있습니다. 예를 들어, 2018년 6월 전문 제약사 AcelRx Pharmaceuticals, Inc.는 의료 모니터링 중인 성인의 급성 중등도에서 중증의 통증 관리를 위한 'DZUVEO'에 대해 유럽위원회(EC)의 승인을 획득했습니다. 시장에서는 인수합병(M&A) 활동이 증가하고 있습니다. 예를 들어, Grunenthal은 미국 내 사업 기반을 확대하기 위해 미국에 본사를 둔 제약회사 Averitas Pharma를 인수했습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트도 제공합니다.
- 본 조사는 다음과 같은 매개 변수를 기반으로 세계 오피오이드 의약품 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로 기업 개요, 재무 실적, 제품 포트폴리오, 사업 전개 지역, 유통 전략, 주요 개발 및 전략, 향후 계획 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 기술 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 세계 오피오이드 의약품 시장 보고서는 투자자, 공급업체, 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 오피오이드 의약품 시장을 분석하는 데 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 오피오이드 약물 시장 : 약제 클래스별, 2021-2033년
제5장 세계의 오피오이드 약물 시장 : 용도별, 2021-2033년
제6장 세계의 오피오이드 약물 시장 : 투여 경로별, 2021-2033년
제7장 세계의 오피오이드 약물 시장 : 유통 채널별, 2021-2033년
제8장 세계의 오피오이드 약물 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 섹션
LSH 26.06.12Opioid Drugs Market is estimated to be valued at USD 49.70 Bn in 2026 and is expected to reach USD 63.23 Bn by 2033, growing at a compound annual growth rate (CAGR) of 3.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 49.70 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 3.50% | 2033 Value Projection: | USD 63.23 Bn |
Opioids are a class of drugs which are largely used for relieving pain. One of the first opioid drugs 'morphine' was developed in 1803. Opioid drugs act on the opioid receptors present in the central and peripheral nervous system thus providing relief from pain. Opioid are administered in the form of as oral pills, parenteral, liquids, patches or lozenges. There are different types of prescription opioids available such as fentanyl, oxycodone, morphine, codeine, oxymorphone, and hydrocodone which are prescribed by physicians for treating pain.
Market Dynamics
Increasing R&D in synthesis of hybrids targeting opioid and neurokinin receptors is expected to offer lucrative growth opportunities for market players. For instance, in December 2019, researchers from Medical University of Lodz reported the synthesis, structure-activity relationship, and pharmacological characterization of a series of hybrids combining opioid pharmacophores with either substance P (SP) fragments or neurokinin receptor (NK1) antagonist fragments in order to comprehend the role of the neurokinin system in opioid-induced antinociception.
Key players in the market are focused on product approvals and launches to expand their product portfolio. For instance, in June 2018, AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company received the European Commission (EC) approval for DZUVEO for the management of acute moderate to severe pain in adults in medically monitored settings. The market is witnessing increasing merger and acquisition activities. For instance, Grunenthal acquired the U.S.-based pharmaceutical company 'Averitas Pharma' in order to expand its presence in the U.S.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global opioids market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Endo International plc, Lupin Limited, Cadila Healthcare Limited, Purdue Pharma L.P., AbbVie Inc., Fresenius Kabi, Mallinckrodt Pharmaceuticals, Pfizer Inc., Rhodes Pharmaceuticals L.P., Sun Pharmaceutical Industries Limited, Nesher Pharmaceuticals (USA) LLC, Amneal Pharmaceuticals LLC, Trevena Inc., and Aurobindo Pharma Limited
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global opioids market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global opioids market
Market Segmentation
- Drug Class Insights (Revenue, USD Bn, 2026 - 2033)
- Alkaloids
- Semisynthetic Opioids
- Synthetic Opioids
- Application Insights (Revenue, USD Bn, 2026 - 2033)
- Analgesia
- Cough Suppression
- Diarrhea Suppression
- Route of Administration Insights (Revenue, USD Bn, 2026 - 2033)
- Oral
- Topical
- Parenteral
- Others
- Distribution Channel Insights (Revenue, USD Bn, 2026 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
- Key Players Insights
- Teva Pharmaceutical Industries Ltd.
- Johnson & Johnson
- Endo International plc
- Lupin Limited
- Cadila Healthcare Limited
- Purdue Pharma L.P.
- AbbVie Inc.
- Fresenius Kabi
- Mallinckrodt Pharmaceuticals
- Pfizer Inc.
- Rhodes Pharmaceuticals L.P.
- Sun Pharmaceutical Industries Limited
- Nesher Pharmaceuticals (USA) LLC
- Amneal Pharmaceuticals LLC
- Trevena Inc.
- Aurobindo Pharma Limited
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Application
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- Reimbursement Scenario
- PEST Analysis
- PORTER'S Analysis
4. Global Opioid Drugs Market, By Drug Class, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Alkaloids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Morphine
- codeine
- Semisynthetic Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Oxycodone
- Hydrocodone
- Hydromorphone
- Synthetic Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Fentanyl
- Alfentanil
5. Global Opioid Drugs Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Analgesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Cough Suppression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Diarrhea Suppression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
6. Global Opioid Drugs Market, By Route of Administration, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Others (Intramuscular, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
7. Global Opioid Drugs Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Opioid Drugs Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Endo International plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Lupin Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Cadila Healthcare Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Purdue Pharma L.P.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- AbbVie Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Fresenius Kabi
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Mallinckrodt Pharmaceuticals
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Rhodes Pharmaceuticals L.P.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Sun Pharmaceutical Industries Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Nesher Pharmaceuticals (USA) LLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Amneal Pharmaceuticals LLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Trevena Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Aurobindo Pharma Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Teva Pharmaceutical Industries Ltd.
10. Section
- References
- Research Methodology
- About us and Sales Contact
